Christina Vasalou

5PUBLICATIONS
26CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 03, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome.

Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki

|Mar 27, 2024
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression.

Christina Vasalou, Theresa A Proia, Laura Kazlauskas

|Jun 21, 2023
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor.

Iacovos N Michaelides, Gavin W Collie, Ulf Börjesson

|Dec 10, 2021
Quantitative Evaluation of Dendritic Nanoparticles in Mice: Biodistribution Dynamics and Downstream Tumor Efficacy Outcomes.

Christina Vasalou, Douglas Ferguson, Weimin Li

Pageof 1